Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. Reply

N Engl J Med. 2025 Feb 27;392(9):931-932. doi: 10.1056/NEJMc2416778.

Authors

Jinlin Hou¹, Farouk Chughlay², Rémi Kazma²

Affiliations

¹ Nanfang Hospital, Guangzhou, China.
² F. Hoffmann-La Roche, Basel, Switzerland.

PMID: 40009817
DOI: 10.1056/NEJMc2416778

No abstract available

Publication types

Letter
Comment